Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2000110509external-prioritypatent/DE10010509A1/de
Pronalazak se odnosi na nove farmaceutske kompozicije za oralnu upotrebu sa karakteristikama aktivnog sastojka koje variraju. Pomenute formulacije sadrže jedan ili više estara masnih kiselina saharoze kao isključivih kontrolnih agenasa, osim jednog ili više aktivnih sastojaka. Pronalazak se takodje odnosi i na postupak za proizvodnju formulacija granulacijom topljenjem. Nova farmaceutske formulacije poredjani su od onih oblika lekova koji se brže oslobadjaju do onih oblika lekova koji se sporije oslobadjaju.[The invention relates to novel oral pharmaceutical formulations having a variably adjustable release effect. Said formulations contain one or several sucrose fatty acid esters as exclusive release control agents, in addition to one or several active ingredients. The invention also relates to a method for the production of the formulations by fusion granulation or fusion pelletizing. The novel pharmaceutical formulations range from quick release to delayed release medicament forms.
YU66902A2000-03-082001-03-06Farmaceutski preparati koji sadrže estre masnih kiselina saharoze za kontrolisanje oslobađanja aktivnih sastojaka
YU66902A
(sh)
Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators